Psyence Biomedical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 90%.

Top 18 shareholders own 100.11% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
59.4%	Psyence Group Inc.	9,921,314	US$502.0k	98.4%	no data
14.3%	Newcourt SPAC Sponsor LLC	2,389,929	US$120.9k	0%	no data
7.38%	AdvisorShares Investments, LLC	1,232,376	US$62.4k	166%	0.01%
7.15%	Launchpad Ignition Holdings Llc	1,193,888	US$60.4k	0%	no data
5.18%	Tabula Rasa Limited	864,791	US$43.8k	-7.29%	no data
2.02%	Cantor Fitzgerald Asset Management	337,000	US$17.1k	0%	no data
1.89%	Launchpad Capital	316,250	US$16.0k	-15.4%	no data
1.01%	Citadel Advisors LLC	169,251	US$8.6k	0%	no data
0.48%	Stonehage Fleming (Uk) Limited	80,500	US$4.1k	0%	no data
0.29%	Morgan Stanley, Investment Banking and Brokerage Investments	48,407	US$2.4k	142%	no data
0.28%	Jane Street Group, LLC, Asset Management Arm	45,963	US$2.3k	0%	no data
0.21%	Tower Research Capital Europe Limited	34,391	US$1.7k	0%	no data
0.15%	Hudson River Trading LLC, Asset Management Arm	25,765	US$1.3k	42.5%	no data
0.09%	UBS Asset Management AG	15,030	US$760.5	-34.3%	no data
0.09%	Two Sigma Securities, LLC, Asset Management Arm	14,989	US$758.4	0%	no data
0.089%	Virtu Financial LLC, Asset Management Arm	14,899	US$753.9	0%	no data
0.063%	Geode Capital Management, LLC	10,488	US$530.7	0%	no data
0.00001%	JPMorgan Chase & Co, Brokerage and Securities Investments	2	US$0.08	0%	no data